Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
3.720
-0.330 (-8.15%)
At close: Mar 12, 2026, 4:00 PM EDT
3.672
-0.048 (-1.29%)
After-hours: Mar 12, 2026, 8:00 PM EDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $5.17 million as of March 12, 2026. Its market cap has decreased by -68.40% in one year.
Market Cap
5.17M
Enterprise Value
-1.68M
1-Year Change
-68.40%
Ranking
Category
Stock Price
$3.72
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $5.17M, a decrease of -72.04%. That is a compound annual growth rate of -7.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 5.17M | -79.02% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aspire Biopharma Holdings | 6.26M |
| Purple Biotech | 6.02M |
| BioRestorative Therapies | 6.02M |
| Xenetic Biosciences | 5.96M |
| Silexion Therapeutics | 5.94M |
| Aprea Therapeutics | 5.90M |
| Cyclerion Therapeutics | 5.90M |
| Psyence Biomedical | 5.78M |